Matches in Wikidata for { <http://www.wikidata.org/entity/Q86660473> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q86660473 description "2015 թվականի հունվարի 12-ին հրատարակված գիտական հոդված" @default.
- Q86660473 description "article scientifique publié en 2015" @default.
- Q86660473 description "artículu científicu espublizáu en xineru de 2015" @default.
- Q86660473 description "im Januar 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q86660473 description "scientific article published on 12 January 2015" @default.
- Q86660473 description "wetenschappelijk artikel" @default.
- Q86660473 description "наукова стаття, опублікована в січні 2015" @default.
- Q86660473 name "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 name "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 type Item @default.
- Q86660473 label "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 label "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 prefLabel "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 prefLabel "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 P1433 Q86660473-A56BB9B4-9D3E-491D-B9C2-F2923F6ABF90 @default.
- Q86660473 P1476 Q86660473-DA2509F4-FD10-467F-B0E7-993F846E1279 @default.
- Q86660473 P2093 Q86660473-00997F71-DA98-4AAE-8AFA-4F4BABE52A06 @default.
- Q86660473 P2093 Q86660473-57433C76-5279-47FA-8E18-444796EA009E @default.
- Q86660473 P2093 Q86660473-7258D68C-2303-4947-B595-A9824474395C @default.
- Q86660473 P304 Q86660473-D0E440AF-9E07-4C0F-BFEA-C5D57451BDBA @default.
- Q86660473 P31 Q86660473-4C822145-48EA-498D-949F-8CD67085FE48 @default.
- Q86660473 P356 Q86660473-1B1E8860-9079-4445-861D-C3993745EC1F @default.
- Q86660473 P433 Q86660473-5E18A11B-C166-44E9-A6E8-F9AC21D2FC20 @default.
- Q86660473 P478 Q86660473-A793469A-1124-4D46-BD2A-3C463335C8FC @default.
- Q86660473 P577 Q86660473-4A6133F6-338D-466B-AC26-E64268531DA4 @default.
- Q86660473 P698 Q86660473-5AE30492-5071-447A-86A2-2BD9AA240219 @default.
- Q86660473 P356 S2053229614028009 @default.
- Q86660473 P698 25652273 @default.
- Q86660473 P1433 Q27725273 @default.
- Q86660473 P1476 "A new three-dimensional CdII supramolecular framework constructed from the 1-[(1H-tetrazol-5-yl)methyl]-1,4-diazoniabicyclo[2.2.2]octane ligand" @default.
- Q86660473 P2093 "Hui-Ting Wang" @default.
- Q86660473 P2093 "Lin Zhou" @default.
- Q86660473 P2093 "Qiang Li" @default.
- Q86660473 P304 "93-96" @default.
- Q86660473 P31 Q13442814 @default.
- Q86660473 P356 "10.1107/S2053229614028009" @default.
- Q86660473 P433 "Pt 2" @default.
- Q86660473 P478 "71" @default.
- Q86660473 P577 "2015-01-12T00:00:00Z" @default.
- Q86660473 P698 "25652273" @default.